211 related articles for article (PubMed ID: 32070759)
1. Flow-through cell-based in vitro release method for triamcinolone acetonide poly (lactic-co-glycolic) acid microspheres.
Tipnis NP; Shen J; Jackson D; Leblanc D; Burgess DJ
Int J Pharm; 2020 Apr; 579():119130. PubMed ID: 32070759
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions.
Doty AC; Zhang Y; Weinstein DG; Wang Y; Choi S; Qu W; Mittal S; Schwendeman SP
Eur J Pharm Biopharm; 2017 Apr; 113():24-33. PubMed ID: 27865933
[TBL] [Abstract][Full Text] [Related]
3. Accelerated in vitro release testing method for naltrexone loaded PLGA microspheres.
Andhariya JV; Choi S; Wang Y; Zou Y; Burgess DJ; Shen J
Int J Pharm; 2017 Mar; 520(1-2):79-85. PubMed ID: 28153651
[TBL] [Abstract][Full Text] [Related]
4. Goserelin Acetate Loaded Poloxamer Hydrogel in PLGA Microspheres: Core-Shell Di-Depot Intramuscular Sustained Release Delivery System.
Qi P; Bu R; Zhang H; Yin J; Chen J; Zhang A; Gou J; Yin T; Zhang Y; He H; Wang P; Tang X; Wang Y
Mol Pharm; 2019 Aug; 16(8):3502-3513. PubMed ID: 31251642
[TBL] [Abstract][Full Text] [Related]
5. Entecavir-loaded poly (lactic-co-glycolic acid) microspheres for long-term therapy of chronic hepatitis-B: Preparation and in vitro and in vivo evaluation.
Zhang C; Wang A; Wang H; Yan M; Liang R; He X; Fu F; Mu H; Sun K
Int J Pharm; 2019 Apr; 560():27-34. PubMed ID: 30711615
[TBL] [Abstract][Full Text] [Related]
6. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
Doty AC; Hirota K; Olsen KF; Sakamoto N; Ackermann R; Feng MR; Wang Y; Choi S; Qu W; Schwendeman A; Schwendeman SP
Biomaterials; 2016 Dec; 109():88-96. PubMed ID: 27693924
[TBL] [Abstract][Full Text] [Related]
7. Accelerated in vitro release testing method for a long-acting peptide-PLGA formulation.
Goel M; Leung D; Famili A; Chang D; Nayak P; Al-Sayah M
Eur J Pharm Biopharm; 2021 Aug; 165():185-192. PubMed ID: 33992753
[TBL] [Abstract][Full Text] [Related]
8. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres.
Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
J Control Release; 2019 Aug; 308():1-13. PubMed ID: 31301338
[TBL] [Abstract][Full Text] [Related]
9. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends.
Wang T; Xue P; Wang A; Yin M; Han J; Tang S; Liang R
Eur J Pharm Sci; 2019 Oct; 138():104990. PubMed ID: 31302216
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres.
Doty AC; Weinstein DG; Hirota K; Olsen KF; Ackermann R; Wang Y; Choi S; Schwendeman SP
J Control Release; 2017 Jun; 256():19-25. PubMed ID: 28342981
[TBL] [Abstract][Full Text] [Related]
11. Liquid jet breakup: A new method for the preparation of poly lactic-co-glycolic acid microspheres.
Xia Y; Yuan M; Chen M; Li J; Ci T; Ke X
Eur J Pharm Biopharm; 2019 Apr; 137():140-147. PubMed ID: 30818010
[TBL] [Abstract][Full Text] [Related]
12. The effect of PLGA molecular weight differences on risperidone release from microspheres.
Kohno M; Andhariya JV; Wan B; Bao Q; Rothstein S; Hezel M; Wang Y; Burgess DJ
Int J Pharm; 2020 May; 582():119339. PubMed ID: 32305366
[TBL] [Abstract][Full Text] [Related]
13. Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta.
Rawat A; Stippler E; Shah VP; Burgess DJ
Int J Pharm; 2011 Nov; 420(2):198-205. PubMed ID: 21889583
[TBL] [Abstract][Full Text] [Related]
14. Reverse Engineering the 1-Month Lupron Depot®.
Zhou J; Hirota K; Ackermann R; Walker J; Wang Y; Choi S; Schwendeman A; Schwendeman SP
AAPS J; 2018 Oct; 20(6):105. PubMed ID: 30280294
[TBL] [Abstract][Full Text] [Related]
15. Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review.
Hua Y; Su Y; Zhang H; Liu N; Wang Z; Gao X; Gao J; Zheng A
Drug Deliv; 2021 Dec; 28(1):1342-1355. PubMed ID: 34180769
[TBL] [Abstract][Full Text] [Related]
16. Interfacial Fast Release Layer in Monodisperse Poly (lactic-co-glycolic acid) Microspheres Accelerates the Drug Release.
Wu J; Zhao X; Yeung KW; To MK
Curr Drug Deliv; 2016; 13(5):720-9. PubMed ID: 26638974
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel and etoposide-loaded Poly (lactic-co-glycolic acid) microspheres fabricated by coaxial electrospraying for dual drug delivery.
Zhang M; Tang Y; Zhu Z; Zhao H; Yao J; Sun D
J Biomater Sci Polym Ed; 2018 Nov; 29(16):1949-1963. PubMed ID: 29920151
[TBL] [Abstract][Full Text] [Related]
18. Formulation, characterization, and evaluation of ketorolac tromethamine-loaded biodegradable microspheres.
Sinha VR; Trehan A
Drug Deliv; 2005; 12(3):133-9. PubMed ID: 16025842
[TBL] [Abstract][Full Text] [Related]
19. In vitro-in vivo correlation of parenteral risperidone polymeric microspheres.
Shen J; Choi S; Qu W; Wang Y; Burgess DJ
J Control Release; 2015 Nov; 218():2-12. PubMed ID: 26423236
[TBL] [Abstract][Full Text] [Related]
20. In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres.
Li S; Shi X; Xu B; Wang J; Li P; Wang X; Lou J; Li Z; Yang C; Li S; Zhen P
J Biomater Appl; 2022 Apr; 36(9):1676-1688. PubMed ID: 35015589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
